| Aug 8 |
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 8 |
Iovance Biotherapeutics: Q2 Earnings Snapshot
|
| Aug 8 |
Iovance Biotherapeutics GAAP EPS of -$0.34 beats by $0.01, revenue of $31.1M beats by $6.54M
|
| Aug 8 |
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
|
| Aug 7 |
Iovance Biotherapeutics Q2 2024 Earnings Preview
|
| Aug 6 |
Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy?
|
| Aug 6 |
AquaBounty Technologies, Inc. (AQB) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 1 |
Iovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
| Jul 31 |
Bullish Iovance Biotherapeutics Insiders Loaded Up On US$74.9m Of Stock
|
| Jul 31 |
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?
|
